TeDan Surgical Innovations
Private Company
Total funding raised: $2.8M
Overview
TeDan Surgical Innovations (TSI) is a private, commercial-stage medical device company that has established itself as a key player in the surgical access market, particularly within spine surgery. The company's growth strategy is built on a portfolio of procedure-specific access systems, strategic acquisitions forming the TSI Group, and expansion into international markets like Europe. Recent milestones include a partnership with AO Spine for cervical solutions, the launch of next-generation systems like the Phantom ML3 and Phantom UL zdATP, and its acquisition by the Halma Group, which provides significant resources for future innovation and scaling.
Technology Platform
Design and manufacturing of integrated, procedure-specific mechanical surgical access systems, including retractors, dilators, blade systems, articulating arms, and instrument sets for spine, cardiothoracic, and neurological procedures.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
TSI competes in the surgical access segment against major spine-focused device companies like Medtronic, Stryker, NuVasive, and Globus Medical, who offer integrated access systems as part of broader implant and technology portfolios. It differentiates through a focused, surgeon-collaborative design philosophy and a comprehensive portfolio covering multiple spinal approaches. The partnership with AO Spine provides a unique competitive advantage in cervical surgery.